Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.00
+0.32 (3.05%)
Mar 9, 2026, 1:27 PM EDT - Market open
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $866.39 million as of March 9, 2026. Its market cap has increased by 128.71% in one year.
Market Cap
866.39M
Enterprise Value
1.33B
1-Year Change
128.71%
Ranking
Category
Stock Price
$11.00
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $866.39M, an increase of 64.36%. That is a compound annual growth rate of 8.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arbutus Biopharma | 871.23M |
| Arvinas | 869.87M |
| Janux Therapeutics | 841.91M |
| Sana Biotechnology | 840.63M |
| Evommune | 835.39M |
| BridgeBio Oncology Therapeutics | 833.94M |
| Xencor | 830.19M |
| KalVista Pharmaceuticals | 820.37M |